Porphyromonas gingivalis Induces Endothelial Dysfunction Through Sirt3-Dependent CypD Acetylation

Shengming Xu1, Cheng Zheng1, Jianmin Huang1

  • 1Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Abstract

Insights

Porphyromonas gingivalis infection causes mitochondrial and endothelial dysfunction. Sirtuin 3 (Sirt3) activation reverses this damage by deacetylating Cyclophilin D (CypD), restoring cellular function.

Area of Science:

  • Cardiovascular Biology
  • Microbiology
  • Mitochondrial Medicine

Background:

  • Porphyromonas gingivalis (P. gingivalis) is linked to cardiovascular diseases.
  • Endothelial dysfunction is a key factor in atherosclerosis and other cardiovascular pathologies.
  • Mitochondrial dysfunction contributes to endothelial cell damage.

Purpose of the Study:

  • To elucidate the mechanism by which P. gingivalis induces endothelial dysfunction.
  • To investigate the role of Sirtuin 3 (Sirt3) in regulating mitochondrial function during P. gingivalis infection.
  • To determine if Sirt3 activation can ameliorate P. gingivalis-induced cellular damage.

Main Methods:

  • RNA sequencing to identify Sirtuin gene expression changes in P. gingivalis-infected human aortic endothelial cells (HAECs).
  • Assessment of mitochondrial and endothelial function in HAECs treated with P. gingivalis and a Sirt3 agonist (Honokiol).
  • Investigation of the Sirt3-Cyclophilin D (CypD) interaction using molecular biology techniques and evaluation of aortic vasorelaxation in infected mice.

Main Results:

  • P. gingivalis infection led to mitochondrial and endothelial dysfunction in HAECs.
  • Sirt3-dependent deacetylation of CypD at K167 was identified as a critical protective mechanism.
  • In vivo studies showed P. gingivalis impaired vasodilation, disrupted endothelial integrity, and increased oxidative stress, all reversed by Sirt3 activation.

Conclusions:

  • P. gingivalis infection induces mitochondrial and endothelial dysfunction.
  • This dysfunction is mediated by a pathway involving Sirt3 and its deacetylation of CypD.
  • Sirt3 activation represents a potential therapeutic strategy against P. gingivalis-associated vascular damage.